Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan and Watson Pharmaceuticals have announced that Mylan has acquired Watson's 50% interest in the Somerset Pharmaceuticals joint venture.
Subscribe to our email newsletter
Somerset, a proprietary research and development company located in Tampa, Florida, was formed in 1986, and since 1988, has been owned jointly by both Mylan and Watson.
Somerset developed Emsam, a transdermal patch for the treatment of major depressive disorder, currently marketed in the US by Bristol-Myers Squibb. Somerset will become a wholly-owned subsidiary of Mylan.